Patents by Inventor John Regan

John Regan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20120245986
    Abstract: A system and method allows a consumer to purchase goods and services from merchants and redeem offers made by a merchant with a digital transaction on a smart phone. The merchant receives and enters the consumer's telephone number into an application. The consumer's telephone number is sent to a server, which checks for electronic coupons and loyalty points. Accounting for the value of any coupon/accumulated loyalty points, the merchant enters the payment amount into the application. which. in turn sends it back to the server. The server then sends the payment amount, any coupon details and the merchant's name to the consumer's phone. The consumer can choose to accept or decline the sale with or without using the coupon/loyalty points. A PIN number confirms the sale, which transmits to the server and then to the merchant. A digital sales receipt is sent to the merchant and consumer.
    Type: Application
    Filed: March 2, 2012
    Publication date: September 27, 2012
    Applicant: PXT Payments Inc
    Inventors: John Regan, Michael Irvine, Keith Saunders, Craig Henkels
  • Publication number: 20120226308
    Abstract: A device for closing an opening in a tissue includes a closure body, a fastening element, and a capture strip coupleable to the closure body such that the capture strip is moveable from a first position to a second position relative to the closure body, the capture strip including a receptacle configured to receive the fastening element when the capture strip is in the first position such that movement of the capture strip from the first position to the second position causes the fastening element to urge the closure body toward the tissue.
    Type: Application
    Filed: December 30, 2011
    Publication date: September 6, 2012
    Applicant: VIVASURE MEDICAL LIMITED
    Inventors: Christopher Martin, Gerard Brett, Peter Grant, Damien Ryan, Michael Dunning, Desmond John Regan
  • Patent number: 8178568
    Abstract: Compounds which modulate the CB2 receptor are disclosed. Compounds according to the invention bind to and are agonists of the CB2 receptor, and are useful for treating inflammation. Those compounds which are agonists are additionally useful for treating pain.
    Type: Grant
    Filed: June 24, 2009
    Date of Patent: May 15, 2012
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: John Regan, Doris Riether
  • Publication number: 20110224728
    Abstract: The present invention relates generally to a closure system for use in surgical procedures.
    Type: Application
    Filed: December 30, 2010
    Publication date: September 15, 2011
    Applicant: VIVASURE MEDICAL LTD.
    Inventors: Christopher Martin, Damien Ryan, Peter Grant, Michael Dunning, Gerard Brett, Kevin Walsh, Desmond John Regan
  • Publication number: 20110124696
    Abstract: Compounds which modulate the CB2 receptor are disclosed. Compounds according to the invention bind to and are agonists of the CB2 receptor, and are useful for treating inflammation. Those compounds which are agonists are additionally useful for treating pain.
    Type: Application
    Filed: June 24, 2009
    Publication date: May 26, 2011
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: John Regan, Doris Riether
  • Publication number: 20090211963
    Abstract: An interceptor having a filter chamber, an inlet passage connected to the filter chamber at an inlet opening, and an outlet passage connected to the filter chamber at an outlet opening. The outlet opening is above the inlet opening and has a minimum outlet flow elevation at which fluid can pass therethrough. A filter may be in the filter chamber between the inlet and outlet openings such that fluid passing from the inlet opening to the outlet opening must pass through the filter. A bypass passage fluidly connects the inlet passage to the outlet passage. The bypass may have a minimum bypass flow elevation at which fluid can pass through the bypass passage, the minimum bypass flow elevation being higher than the minimum outlet flow elevation. The bypass may be adapted to allow flow therethrough only when a flow resistance between the inlet and the filter exceeds a threshold value.
    Type: Application
    Filed: February 27, 2008
    Publication date: August 27, 2009
    Inventors: Christopher Adam Murray, Balreet Singh Dandiwal, John Regan Walker
  • Patent number: 7245285
    Abstract: A pixel device, comprising; a first plate, a second plate disposed under the first plate, and a third plate disposed under the second plate; a first power supply for providing a first voltage to the first plate; a second power supply for providing a second voltage to the second plate; and a third power supply for providing a third voltage to the third plate.
    Type: Grant
    Filed: April 28, 2004
    Date of Patent: July 17, 2007
    Assignee: Hewlett-Packard Development Company, L.P.
    Inventors: Bao-Sung Bruce Yeh, James Richard Przybyla, Michael John Regan
  • Publication number: 20070155724
    Abstract: Disclosed are methods of treating acute and chronic inflammation in the lung caused by inhalation of smoke, endometriosis, Behcet's disease, uveitis, ankylosing spondylitis, pancreatitis, cancer, Lyme disease, sepsis, chronic obstructive pulmonary disease, traumatic arthritis, congestive heart failure and restenosis following percutaneous transluminal coronary angioplasty, known to be cytokine mediated, using aromatic heterocyclic compounds described in WO 00/55139.
    Type: Application
    Filed: March 9, 2007
    Publication date: July 5, 2007
    Inventors: Neil MOSS, John Regan
  • Publication number: 20070022051
    Abstract: A multi-application payment system and method operates in a hybrid closed/open manner. The multi-application payment system and method features a smart card wherein funds are added to the card at point of sale (POS) locations. The card keeps track of the available balance and is used to purchase goods/services at any POS location. During a transaction, the POS location verifies the amount of funds available and then debits the funds available on the card. Transactions between the card and the POS location are preformed in a substantially closed manner. The POS location then transfers data about the transaction (preferably in a batch manner) to a central processing system. The central processing system processes the data in a generally open manner to move funds to the appropriate account, preferably using the Federal ACH interface.
    Type: Application
    Filed: May 18, 2006
    Publication date: January 25, 2007
    Applicant: Parcxmart Technologies, Inc.
    Inventors: John Regan, Michael Irvine, Mark Connolly, Gerard Kiley
  • Publication number: 20060189646
    Abstract: Compounds of Formula (I) wherein R1, R2, R3, R4, R5, R6, and R7 are as defined herein, or a tautomer, prodrug, solvate, or salt thereof; pharmaceutical compositions containing such compounds, and methods of modulating the glucocorticoid receptor function and methods of treating disease-states or conditions mediated by the glucocorticoid receptor function or characterized by inflammatory, allergic, or proliferative processes in a patient using these compounds.
    Type: Application
    Filed: December 16, 2005
    Publication date: August 24, 2006
    Applicant: Boehringer Ingelheim Pharmaceuticals, Inc.
    Inventors: Daniel Kuzmich, Darren DiSalvo, John Regan, David Thomson, Rajashekhar Betageri, Jennifer Kowalski
  • Publication number: 20060154925
    Abstract: Compounds of Formula (I) wherein R1, R2, R3, R4, R5, R6, and R7 are as defined herein, or a tautomer, prodrug, solvate, or salt thereof; pharmaceutical compositions containing such compounds, and methods of modulating the glucocorticoid receptor function and methods of treating disease-states or conditions mediated by the glucocorticoid receptor function or characterized by inflammatory, allergic, or proliferative processes in a patient using these compounds.
    Type: Application
    Filed: December 16, 2005
    Publication date: July 13, 2006
    Applicant: Boehringer Ingelheim Pharmaceuticals, Inc.
    Inventors: Daniel Kuzmich, Darren DiSalvo, John Regan, David Thomson
  • Publication number: 20050234091
    Abstract: Compounds of Formula (I) wherein R1, R2, R3, R4, R5, R6 and X are as defined herein for Formula (IA) and Formula (IB), or a tautomer, prodrug, solvate, or salt thereof; pharmaceutical compositions containing such compounds, and methods of modulating the glucocorticoid receptor function and methods of treating disease-states or conditions mediated by the glucocorticoid receptor function or characterized by inflammatory, allergic, or proliferative processes in a patient using these compounds.
    Type: Application
    Filed: March 4, 2005
    Publication date: October 20, 2005
    Applicant: Boehringer Ingelheim Pharmaceuticals, Inc.
    Inventors: John Regan, Thomas Lee, David Thomson, Thomas Kirrane, Daniel Kuzmich, John Proudfoot, Younes Bekkali, Renee Zindell
  • Publication number: 20050222947
    Abstract: A system and method for transaction processing includes a central repository of transaction information which can be accessed by a variety of participants who may be located over a wide geographic area in the recovery process of a property unit such as a vehicle or other collateral. Interfacing with a variety of computer systems over a communication network, such as the Internet, allows interchange of data relating to the recovery process and centralized coordination of the recovery process.
    Type: Application
    Filed: May 16, 2005
    Publication date: October 6, 2005
    Inventor: John Regan
  • Publication number: 20050175605
    Abstract: A gene encoding the HP4 human prostaglandin receptor is disclosed. The protein encoded by this gene exhibits significant sequence identity with other prostaglandin receptors. The HP4 receptor, when expressed in eukaryotic cells, is capable of binding prostaglandins and their analogs and stimulating adenylate cyclase activity in response to prostaglandins. Also disclosed are antisense agents able to decrease or prevent translation of a human HP4 prostaglandin receptor.
    Type: Application
    Filed: March 17, 2005
    Publication date: August 11, 2005
    Inventors: John Regan, Daniel Gil, David Woodward
  • Patent number: 6903487
    Abstract: A micro-mirror device includes a substrate, at least one electrode formed on the substrate, and a reflective element spaced from the substrate and extending beyond the at least one electrode. The reflective element is adapted to move between a first position and at least one second position, and, when the reflective element is in the at least one second position, a minimum distance between the reflective element and the at least one electrode is greater than a minimum distance between the reflective element and the substrate.
    Type: Grant
    Filed: February 14, 2003
    Date of Patent: June 7, 2005
    Assignee: Hewlett-Packard Development Company, L.P.
    Inventors: Robert W. Shreeve, Eric Lee Nikkel, Michael John Regan, Sam G. Angelos, Jr.
  • Patent number: 6876294
    Abstract: A transponder identification system comprising a plurality of transponders and an interrogation device arranged to identify each of the transponders by transmitting successive interrogation signals according to a systematic search strategy, wherein the search is truncated where the interrogation device receives fewer than a predetermined number of different responses from the transponders, to a transmitted interrogation signal.
    Type: Grant
    Filed: August 18, 1999
    Date of Patent: April 5, 2005
    Assignee: Identec Limited
    Inventor: Bernard John Regan
  • Publication number: 20050038069
    Abstract: This invention is directed to physiologically active compounds of formula (I) wherein represents a bicyclic ring system, of about 10 to about 13 ring members, in which the ring is an azaheterocycle, and the ring represents an azaheteroaryl ring, or an optionally halo substituted benzene ring; R1 represents hydrogen or a straight- or branched-chain alkyl group of 1 to about 4 carbon atoms, optionally substituted by hydroxy or one or more halogen atoms, or when Z1 represents a direct bond R1 may also represent a lower alkenyl or lower alkynyl group, or a formyl group; R2 represents hydrogen, alkenyl, alkoxy, alkyl, alkylsulphinyl, alkylsulphonyl, alkylthio, aryl, arylalkyloxy, arylalkylsulphinyl, arylalkylsulphonyl, arylalkylthio, aryloxy, arylsulphinyl, arylsulphonyl, arylthio, cyano, cycloalkenyl, cycloalkenyloxy, cycloalkyl, cycloalkyloxy, heteroaryl, heteroarylalkyloxy, heteroaryloxy, hydroxy, —SO2NR4R5, —NR4SO2R5, —NR4R5, —C(?O)R5, —C(?O)C(?O)R5, —C(?O)NR4R5, —C(?O)OR5, —O(C?O)NR4R5, or
    Type: Application
    Filed: September 1, 2004
    Publication date: February 17, 2005
    Applicant: AVENTIS PHARMA LIMITED
    Inventors: Paul Cox, Shelley Bower, David Aldous, Peter Astles, Daniel McGarry, Christopher Hulme, John Regan, Fu-Chih Huang, Stevan Djuric, Kevin Moriarty, Rose Mathew, Gregory Poli
  • Publication number: 20040160143
    Abstract: A micro-mirror device includes a substrate, at least one electrode formed on the substrate, and a reflective element spaced from the substrate and extending beyond the at least one electrode. The reflective element is adapted to move between a first position and at least one second position, and, when the reflective element is in the at least one second position, a minimum distance between the reflective element and the at least one electrode is greater than a minimum distance between the reflective element and the substrate.
    Type: Application
    Filed: February 14, 2003
    Publication date: August 19, 2004
    Inventors: Robert W. Shreeve, Eric Lee Nikkel, Michael John Regan, Sam G. Angelos
  • Publication number: 20040029639
    Abstract: This invention is directed to a method and system for generating, archiving, and retrieving information associated with winnings received by a patron from casino games. A system user inputs transaction information about a patron's winning and transmits the information to a document output module, which parses the transaction information to create index data and then generates bar codes from the index data. It then determines whether the winnings are over a specified tax reporting limit and if the winnings are over such limit, generating a tax form containing selected transaction information, tax information, and the bar codes associated therewith. Transaction related forms containing selected transaction information and the bar codes associated therewith are also generated.
    Type: Application
    Filed: August 8, 2002
    Publication date: February 12, 2004
    Inventor: John Regan
  • Patent number: 5882550
    Abstract: A fire retardant agent to be incorporated in a plastic, especially polyurethane foam which functions as a foaming agent and comprises a mixture of soluble ammonium salts selected from the group consisting of ammonium monophosphate, ammonium diphosphate and an ammonium halide; and urea. Processes and apparatus for the production of a polyurethane foam are also described.
    Type: Grant
    Filed: October 1, 1996
    Date of Patent: March 16, 1999
    Assignee: Bains Harding Limited
    Inventor: Christopher John Regan